Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors.
暂无分享,去创建一个
N. Chalasani | A. Naing | E. Miller | B. Blechacz | G. N. Nogueras Gonzalez | Hamzah Abu-Sbeih | Brett A Styskel
暂无分享,去创建一个
N. Chalasani | A. Naing | E. Miller | B. Blechacz | G. N. Nogueras Gonzalez | Hamzah Abu-Sbeih | Brett A Styskel